FirstEnergy Free cash flow decreased by 3590.0% to -$1.11B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 200.8%, from -$368.00M to -$1.11B. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a 31.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $192.00M | $215.00M | $0.00 | -$184.00M | $281.00M | -$112.00M | -$150.00M | -$761.00M | -$870.00M | -$206.00M | -$132.00M | -$830.00M | $170.00M | -$229.00M | -$250.00M | -$368.00M | -$136.00M | -$471.00M | -$30.00M | -$1.11B |
| QoQ Change | — | +12.0% | -100.0% | — | +252.7% | -139.9% | -33.9% | -407.3% | -14.3% | +76.3% | +35.9% | -528.8% | +120.5% | -234.7% | -9.2% | -47.2% | +63.0% | -246.3% | +93.6% | <-999% |
| YoY Change | — | — | — | — | +46.4% | -152.1% | — | -313.6% | -409.6% | -83.9% | +12.0% | -9.1% | +119.5% | -11.2% | -89.4% | +55.7% | -180.0% | -105.7% | +88.0% | -200.8% |